The 12 closest competitors and alternatives to Magnus Medical, Inc. among neurotech companies — ranked by similarity to what Magnus Medical, Inc. actually does, not by market-cap band.
Subscribe to see Magnus Medical, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Magnus Medical, Inc. is a privately held therapeutic neuromodulation company founded in 2020 to advance precision medicine in brain health. The company protects and develops intellectual property behind therapies such as the SAINT therapy system.
Magnus Medical, Inc. is a neurotech company headquartered in United States. Its most recent funding round raised $49M in May 2025. Xcout tracks 16 named people at Magnus Medical, Inc., including Achal Singh Achrol (Chief Executive Officer).
10 more named people on record for Magnus Medical, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $49M | — | |
| SEC Form D filing | $40.3M | — | |
| — | $25M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Magnus Medical, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Medtech
IAMA Therapeutics is a clinical-stage pharmaceutical and biotechnology company founded in 2021 and headquartered in Genoa, Italy. The firm is dedicated to researching and developing innovative, disease-modifying medicines to treat brain disorders.
Biopharmaceuticals
BrainEver is a privately held biopharmaceutical company headquartered in Paris, France, focused on developing a pipeline of novel therapies.
Biopharmaceuticals
AgeneBio, Inc. is a development-stage CNS biopharmaceutical company located in Baltimore, Maryland, focused on discovering and developing innovative therapeutics to preserve and restore brain function.
Neuroscience
RAPT Ventures, Inc. develops home-based neuroscience products that utilize structured auditory experiences to enhance and maintain brain performance. The company leverages neuroplasticity to support cognitive functions and brain structure across all life stages, ranging from language processing foundations in infants to neural system maintenance in older adults.
Medtech
INBRAIN Neuroelectronics develops graphene-based brain-computer interface (BCI) platforms and AI-driven neurotherapeutics designed to decode and modulate neural signals. The company serves patients with brain disorders and neurological conditions, such as Parkinson's disease, by providing real-time, personalized autonomous therapy.
Drug Discovery
Cognito Therapeutics Ltd. is a clinical-stage company headquartered in Cambridge, Massachusetts, that has conducted multiple clinical studies for its therapeutic products.
Drug Discovery
Neurasic Therapeutics is a Montreal-based drug discovery company founded in 2020 and based on research from McGill University's Montreal Neurological Institute. The company develops therapeutic solutions and medicinal drugs aimed at treating neurological disorders, with a primary focus on advancing opiate-sparing, pain-relieving treatments such as substituted thiophene for neuropathic and inflammatory pain.
Lifestyle
Egra is a technology company that develops a general-purpose foundation model for EEG, designed to learn from brain signals by aggregating clinical-grade EEG data.
Decision/Risk Analysis
Gray Matter Solutions Pte. Ltd. is a Singapore-based MedTech spin-off from Nanyang Technological University's LKCMedicine. Headquartered in Singapore, the company develops registered software medical devices focused on early cognitive decline detection. It provides advanced digital health solutions targeted at neurological assessment and care.
Crypto/Web3
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.
Holding
Santo Holding AG is a multi-family office established in 2001 and based in Zug, Switzerland, that directs capital into biotechnology, pharmaceuticals, and healthcare ventures. Its subsidiary, Santo Holding (Deutschland) GmbH, engages in the acquisition, management, and sale of shareholdings in other companies and is associated with the Strüngmann Group.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Magnus Medical, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →